Join the Class Action Against PepGen Inc. with Confidence

Author: Owen Jenkins Updated: 07-21-2025 09:00 AM

Take Action: Class Action Against PepGen Inc.

The Gross Law Firm has initiated an important opportunity for shareholders of PepGen Inc. (NASDAQ: PEPG) to participate in a class action lawsuit. If you invested in PepGen during the specific period defined by the firm, it’s essential to be aware of your rights and options.

Understanding the Class Period

For shareholders, understanding the class period is crucial. This class action pertains to those who acquired shares from March 7, 2024, to March 3, 2025. This timeframe is significant as it lays the foundation for the claims being made.

Key Allegations Against PepGen

The allegations assert that PepGen's executives issued misleading statements regarding their lead product candidate, PGN-EDO51. Investors were led to believe in the safety and effectiveness of the drug, which is now under scrutiny due to claims that it was inadequately tested in critical studies.

Moreover, the complaint details that the CONNECT2 study was fraught with potential safety issues, raising red flags for the FDA approval process. Consequently, it is alleged that PepGen may have to suspend the study, which could greatly affect the future of PGN-EDO51 and mislead investors regarding its commercial viability.

What You Need to Know About the Deadline

Time is of the essence in this situation. The deadline for shareholders to register for the class action is August 8, 2025. It’s a critical step for those looking to seek recovery from any losses incurred during the class period. If you believe that you qualify, contact The Gross Law Firm to ensure your participation.

Next Steps for Shareholders

Once you have registered your interest as a shareholder, you will gain access to portfolio monitoring tools that will keep you updated on the progress of the case. Participating in this class action has no costs or obligations, making it a valuable opportunity for all shareholders who may have been misled.

Why Choose The Gross Law Firm?

The Gross Law Firm is a highly regarded class action law firm dedicated to safeguarding the rights of investors. With a commitment to fighting against deceptive practices and ensuring accountability in the corporate sector, The Gross Law Firm strives to protect individuals from significant financial losses due to misleading information provided by companies. Their focus on responsible business practices reinforces their mission to uphold investor trust.

Get in Touch

If you would like to connect with The Gross Law Firm, you can find them at their office in New York. They are available to answer any questions and guide potential class members through this process.

Contact Information:
The Gross Law Firm
15 West 38th Street, 12th Floor
New York, NY 10018
Phone: (646) 453-8903

Frequently Asked Questions

What is the class action regarding PepGen Inc.?

The class action involves shareholders of PepGen who purchased shares during the specified class period and allege they were misled by the company's statements regarding product safety and efficacy.

How do I register for the class action?

To register, shareholders should contact The Gross Law Firm and provide required information as outlined for the class action.

What are the key dates I should be aware of?

The class action registration deadline is August 8, 2025, so interested shareholders should act before this date.

Are there any costs associated with joining the class action?

No, there are no costs or obligations for shareholders to join the class action.

How can I find out more about the allegations?

Further details regarding the allegations can be obtained by contacting The Gross Law Firm directly for assistance.

About The Author

Hi there I'm 38-year-old author and financial consultant Owen Jenkins. Having worked in the financial sector for more than ten years, I am well-versed in the subtleties and complexity that mold our financial environment. Following a degree in finance, I worked in a number of financial institutions honing my abilities in market analysis, financial planning, and investment strategies.

My love is teaching others about investing and personal finance. My goal in writing many books and articles has been to demystify financial ideas and give readers the information they need to make wise financial decisions. I write with a direct, useful style that emphasizes doable suggestions for daily living.

Along with writing, I lead webinars and seminars where I impart knowledge on how to successfully negotiate the financial world. I also write for financial journals and show up as a guest expert on financial news programs a lot. Whether they are new to investing or want to improve their approach, my mission is to enable people to take charge of their financial futures.

Beyond work, I like to hike, play the guitar, and spend time with my family. I think that balance is crucial and want to encourage people to strike a balance between their financial aspirations and their hobbies. I want to help people succeed and achieve financial security through my work, so having a good influence.

Contact Owen Jenkins privately here. Or send an email with ATTN: Owen Jenkins as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.